{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T21:51:50Z","timestamp":1783720310197,"version":"3.55.0"},"reference-count":86,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Clin Oncol"],"DOI":"10.3892\/mco.2025.2916","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T10:23:09Z","timestamp":1763115789000},"page":"1-8","source":"Crossref","is-referenced-by-count":1,"title":["Tertiary lymphoid structure can be a potential therapeutic target for head and neck squamous cell carcinoma (Review)\n                    <b\/>"],"prefix":"10.3892","volume":"24","author":[{"given":"Jie","family":"Shen","sequence":"first","affiliation":[{"name":"Department of Stomatology, Ningbo Sixth Hospital Affiliated to Ningbo University, Ningbo, Zhejiang 315040, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Oral and Cranio\u2011Maxillofacial Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology and Shanghai Research Institute of Stomatology; Research Unit of Oral and Maxillofacial Regenerative Medicine, Chinese Academy of Medical Sciences, Shanghai 200011, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"issue":"eabf9419","key":"key20251211105217_b1-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"issue":"225","key":"key20251211105217_b2-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01947-5","article-title":"Tertiary lymphoid structures in diseases: Immune mechanisms and therapeutic advances","volume":"9","author":"Zhao","year":"2024","journal-title":"Signal Transduct Tar"},{"key":"key20251211105217_b3-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1038\/s41591-020-1086-y","article-title":"Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma","volume":"26","author":"Gao","year":"2020","journal-title":"Nat Med"},{"issue":"7713","key":"key20251211105217_b4-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52153-4","article-title":"Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinoma","volume":"15","author":"Liu","year":"2024","journal-title":"Nat Commun"},{"key":"key20251211105217_b5-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1016\/j.arbres.2024.07.020","article-title":"Tertiary lymphoid structure in tumor microenvironment and immunotherapy of lung cancer","volume":"60 (Suppl 2)","author":"Xie","year":"2024","journal-title":"Arch Bronconeumo"},{"issue":"eadk2612","key":"key20251211105217_b6-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adk2612","article-title":"cGAS-activated endothelial cell-T cell cross-talk initiates tertiary lymphoid structure formation","volume":"9","author":"Zhao","year":"2024","journal-title":"Sci Immunol"},{"key":"key20251211105217_b7-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","article-title":"Tertiary lymphoid structures generate and propagate antitumor antibody-producing plasma cells in renal cell cancer","volume":"55","author":"Meylan","year":"2022","journal-title":"Immunity"},{"key":"key20251211105217_b8-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41571-022-00619-z","article-title":"B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome","volume":"19","author":"Fridman","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"key20251211105217_b9-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41581-023-00706-z","article-title":"The roles of tertiary lymphoid structures in chronic diseases","volume":"19","author":"Sato","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"key20251211105217_b10-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41568-024-00728-0","article-title":"Tertiary lymphoid structures in anticancer immunity","volume":"24","author":"Teillaud","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"key20251211105217_b11-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.ccell.2025.03.015","article-title":"Cancer cell-derived arginine fuels polyamine biosynthesis in tumor-associated macrophages to promote immune evasion","volume":"43","author":"Zhu","year":"2025","journal-title":"Cancer Cell"},{"key":"key20251211105217_b12-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.ccell.2025.03.011","article-title":"Spatial transcriptomics reveals tryptophan metabolism restricting maturation of intratumoral tertiary lymphoid structures","volume":"43","author":"Tang","year":"2025","journal-title":"Cancer Cell"},{"key":"key20251211105217_b13-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/s43018-021-00232-6","article-title":"Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression","volume":"2","author":"Vanhersecke","year":"2021","journal-title":"Nat Cancer"},{"issue":"101448","key":"key20251211105217_b14-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101448","article-title":"An immune cell map of human lung adenocarcinoma development reveals an anti-tumoral role of the Tfh-dependent tertiary lymphoid structure","volume":"5","author":"Liu","year":"2024","journal-title":"Cell Rep Med"},{"issue":"677","key":"key20251211105217_b15-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05409-y","article-title":"Spatial dynamics of tertiary lymphoid aggregates in head and neck cancer: Insights into immunotherapy response","volume":"22","author":"Sadeghirad","year":"2024","journal-title":"J Transl Med"},{"key":"key20251211105217_b16-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/cei.13389","article-title":"Oral cancer-associated tertiary lymphoid structures: Gene expression profile and prognostic value","volume":"199","author":"Li","year":"2020","journal-title":"Clin Exp Immunol"},{"issue":"107","key":"key20251211105217_b17-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-025-03952-1","article-title":"Distinct maturity and spatial distribution of tertiary lymphoid structures in head and neck squamous cell carcinoma: Implications for tumor immunity and clinical outcomes","volume":"74","author":"Xu","year":"2025","journal-title":"Cancer Immunol Immunother"},{"issue":"1423775","key":"key20251211105217_b18-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1423775","article-title":"Density of tertiary lymphoid structures and their correlation with prognosis in non-small cell lung cancer","volume":"15","author":"Xin","year":"2024","journal-title":"Front Immunol"},{"issue":"1422206","key":"key20251211105217_b19-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1422206","article-title":"Exploring the impact of tertiary lymphoid structures maturity in NSCLC: Insights from TLS scoring","volume":"15","author":"Berthe","year":"2024","journal-title":"Front Immunol"},{"issue":"67","key":"key20251211105217_b20-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0808-y","article-title":"Clinical significance of plasma cell-free DNA mutations in PIK3CA, AKT1, and ESR1 gene according to treatment lines in ER-positive breast cancer","volume":"17","author":"Takeshita","year":"2018","journal-title":"Mol Cancer"},{"key":"key20251211105217_b21-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"issue":"e1378844","key":"key20251211105217_b22-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1378844","article-title":"Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer","volume":"7","author":"Posch","year":"2017","journal-title":"Oncoimmunology"},{"key":"key20251211105217_b23-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1016\/j.immuni.2021.11.003","article-title":"Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer","volume":"54","author":"Overacre-Delgoffe","year":"2021","journal-title":"Immunity"},{"key":"key20251211105217_b24-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/s41416-023-02235-9","article-title":"Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors","volume":"128","author":"Hayashi","year":"2023","journal-title":"Brit J Cancer"},{"issue":"962056","key":"key20251211105217_b25-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.962056","article-title":"Peritumoral tertiary lymphoid structure and tumor stroma percentage predict the prognosis of patients with non-metastatic colorectal cancer","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"issue":"648812","key":"key20251211105217_b26-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.648812","article-title":"Peritumoral tertiary lymphoid structures correlate with protective immunity and improved prognosis in patients with hepatocellular carcinoma","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol"},{"key":"key20251211105217_b27-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/ni.3290","article-title":"Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma","volume":"16","author":"Finkin","year":"2015","journal-title":"Nat Immunol"},{"key":"key20251211105217_b28-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41591-022-02189-0","article-title":"Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: The phase 2 platform NEOSTAR trial","volume":"29","author":"Cascone","year":"2023","journal-title":"Nat Med"},{"key":"key20251211105217_b29-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nrclinonc.2015.215","article-title":"Clinical relevance of host immunity in breast cancer: From TILs to the clinic","volume":"13","author":"Savas","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"key20251211105217_b30-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1136\/gutjnl-2022-328697","article-title":"Mature tertiary lymphoid structures are key niches of tumour-specific immune responses in pancreatic ductal adenocarcinomas","volume":"72","author":"Kinker","year":"2023","journal-title":"Gut"},{"issue":"1373","key":"key20251211105217_b31-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29040-x","article-title":"Tertiary lymphoid structures critical for prognosis in endometrial cancer patients","volume":"13","author":"Horeweg","year":"2022","journal-title":"Nat Commun"},{"issue":"154882","key":"key20251211105217_b32-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154882","article-title":"Tumor-infiltrating lymphocytes in oral cavity squamous cell carcinoma and its association with clinicopathological parameters","volume":"251","author":"Ahuja","year":"2023","journal-title":"Pathol Res Pract"},{"issue":"216","key":"key20251211105217_b33-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02126-4","article-title":"Deciphering the role of LGALS2: insights into tertiary lymphoid structure-associated dendritic cell activation and immunotherapeutic potential in breast cancer patients","volume":"23","author":"Li","year":"2024","journal-title":"Mol Cancer"},{"key":"key20251211105217_b34-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"key20251211105217_b35-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jhep.2021.10.030","article-title":"Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma","volume":"76","author":"Ding","year":"2022","journal-title":"J Hepatol"},{"issue":"3968","key":"key20251211105217_b36-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59004-w","article-title":"Efficacy, safety and single-cell analysis of neoadjuvant immunochemotherapy in locally advanced oral squamous cell carcinoma: A phase II trial","volume":"16","author":"Xiang","year":"2025","journal-title":"Nat Commun"},{"issue":"2466308","key":"key20251211105217_b37-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2025.2466308","article-title":"Spatial characterization of tertiary lymphoid structures as predictive biomarkers for immune checkpoint blockade in head and neck squamous cell carcinoma","volume":"14","author":"Ruiz-Torres","year":"2025","journal-title":"Oncoimmunology"},{"issue":"e005539","key":"key20251211105217_b38-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005539","article-title":"Intratumoral tertiary lymphoid structure (TLS) maturation is influenced by draining lymph nodes of lung cancer","volume":"11","author":"He","year":"2023","journal-title":"J Immunother Cancer 11: J Immunother Cancer"},{"issue":"41","key":"key20251211105217_b39-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03218-3","article-title":"B cells in head and neck squamous cell carcinoma: Current opinion and novel therapy","volume":"24","author":"Guo","year":"2024","journal-title":"Cancer Cell Int"},{"issue":"1049884","key":"key20251211105217_b40-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1049884","article-title":"Tertiary lymphoid structure patterns aid in identification of tumor microenvironment infiltration and selection of therapeutic agents in bladder cancer","volume":"13","author":"An","year":"2022","journal-title":"Front Immunol"},{"issue":"1096220","key":"key20251211105217_b41-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1096220","article-title":"Follicle-like tertiary lymphoid structures: A potential biomarker for prognosis and immunotherapy response in patients with laryngeal squamous cell carcinoma","volume":"14","author":"Liang","year":"2023","journal-title":"Front Immunol"},{"key":"key20251211105217_b42-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ccell.2022.02.002","article-title":"Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer","volume":"40","author":"Patil","year":"2022","journal-title":"Cancer Cell"},{"key":"key20251211105217_b43-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00535-022-01939-8","article-title":"Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma","volume":"58","author":"Tanaka","year":"2023","journal-title":"J Gastroenterol"},{"key":"key20251211105217_b44-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.jcmgh.2021.06.023","article-title":"Pancreatic cancer chemotherapy is potentiated by induction of tertiary lymphoid structures in mice","volume":"12","author":"Delvecchio","year":"2021","journal-title":"Cell Mol Gastroenter"},{"issue":"75","key":"key20251211105217_b45-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01980-6","article-title":"Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol Cancer"},{"issue":"21530","key":"key20251211105217_b46-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-78560-3","article-title":"Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure","volume":"10","author":"Lin","year":"2020","journal-title":"Sci Rep"},{"key":"key20251211105217_b47-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2019.11.014","article-title":"Immune landscape of viral- and carcinogen-driven head and neck cancer","volume":"52","author":"Cillo","year":"2020","journal-title":"Immunity"},{"issue":"3349","key":"key20251211105217_b48-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23355-x","article-title":"B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma","volume":"12","author":"Ruffin","year":"2021","journal-title":"Nat Commun"},{"key":"key20251211105217_b49-MCO-24-1-02916","author":"Hu"},{"key":"key20251211105217_b50-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s00262-022-03310-5","article-title":"Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma","volume":"72","author":"Liu","year":"2023","journal-title":"Cancer Immunol Immun"},{"key":"key20251211105217_b51-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"S204","DOI":"10.4103\/jpbs.jpbs_593_25","article-title":"A narrative review on oral squamous cell carcinoma","volume":"17 (Suppl 1)","author":"Muralidharan","year":"2025","journal-title":"J Pharm Bioallied Sci"},{"issue":"2904","key":"key20251211105217_b52-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16162904","article-title":"The mutational and microenvironmental landscape of cutaneous squamous cell carcinoma: A review","volume":"16","author":"Hosseini","year":"2024","journal-title":"Cancers (Basel)"},{"key":"key20251211105217_b53-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"74362","DOI":"10.18632\/oncotarget.11413","article-title":"Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma","volume":"7","author":"Bossi","year":"2016","journal-title":"Oncotarget"},{"issue":"105368","key":"key20251211105217_b54-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2021.105368","article-title":"Longitudinal assessment of PD-L1 expression and gene expression profiles in patients with head and neck cancer reveals temporal heterogeneity","volume":"119","author":"Karabajakian","year":"2021","journal-title":"Oral Oncol"},{"issue":"104836","key":"key20251211105217_b55-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.104836","article-title":"Prognostic role of programmed death ligand 1 (PD-L1) and the immune microenvironment in laryngeal carcinoma","volume":"108","author":"Alessandrini","year":"2020","journal-title":"Oral Oncol"},{"issue":"4228","key":"key20251211105217_b56-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59341-w","article-title":"Mature tertiary lymphoid structures evoke intra-tumoral T and B cell responses via progenitor exhausted CD4+ T cells in head and neck cancer","volume":"16","author":"Li","year":"2025","journal-title":"Nat Commun"},{"issue":"1551844","key":"key20251211105217_b57-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1551844","article-title":"A novel tertiary lymphoid structure-associated signature accurately predicts patient prognosis and facilitates the selection of personalized treatment strategies for HNSCC","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"issue":"3946320241227312","key":"key20251211105217_b58-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1177\/03946320241227312","article-title":"CXC ligand 13 orchestrates an immunoactive microenvironment and enhances immunotherapy response in head and neck squamous cell carcinoma","volume":"38","author":"Lin","year":"2024","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"1233085","key":"key20251211105217_b59-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1233085","article-title":"Exploring the dual role of B cells in solid tumors: Implications for head and neck squamous cell carcinoma","volume":"14","author":"Bao","year":"2023","journal-title":"Front Immunol"},{"key":"key20251211105217_b60-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2174\/0113892029278082240118053857","article-title":"Tertiary lymphoid structures gene signature predicts prognosis and immune infiltration analysis in head and neck squamous cell carcinoma","volume":"25","author":"Xing","year":"2024","journal-title":"Curr Genomics"},{"issue":"76","key":"key20251211105217_b61-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.3892\/or.2025.8909","article-title":"Tertiary lymphoid structures in head and neck squamous cell carcinoma (Review)","volume":"54","author":"Hong","year":"2025","journal-title":"Oncol Rep"},{"key":"key20251211105217_b62-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.annonc.2023.12.011","article-title":"B-cell infiltration is associated with survival outcomes following programmed cell death protein 1 inhibition in head and neck squamous cell carcinoma","volume":"35","author":"Gavrielatou","year":"2024","journal-title":"Ann Oncol"},{"issue":"1483497","key":"key20251211105217_b63-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1483497","article-title":"Tertiary lymphoid structure-related score as a predictor for survival prognosis and immunotherapy response in head and neck squamous cell carcinoma","volume":"15","author":"Wu","year":"2024","journal-title":"Front Immunol"},{"issue":"105348","key":"key20251211105217_b64-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2021.105348","article-title":"Single-cell profiling of tumor-infiltrating TCF1\/TCF7+ T cells reveals a T lymphocyte subset associated with tertiary lymphoid structures\/organs and a superior prognosis in oral cancer","volume":"119","author":"Peng","year":"2021","journal-title":"Oral Oncol"},{"issue":"1535293","key":"key20251211105217_b65-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1535293","article-title":"Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma","volume":"8","author":"Lechner","year":"2019","journal-title":"Oncoimmunology"},{"key":"key20251211105217_b66-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1158\/2767-9764.CRC-23-0155","article-title":"Immune cell abundance and T-cell receptor landscapes suggest new patient stratification strategies in head and neck squamous cell carcinoma","volume":"3","author":"Secrier","year":"2023","journal-title":"Cancer Res Commun"},{"issue":"1108","key":"key20251211105217_b67-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10208-z","article-title":"Tertiary lymphoid structures associate with improved survival in early oral tongue cancer","volume":"22","author":"Almangush","year":"2022","journal-title":"BMC Cancer"},{"key":"key20251211105217_b68-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/jop.13215","article-title":"Prognostic value of tertiary lymphoid structures in early clinical stage oral tongue squamous cell carcinoma","volume":"50","author":"Wang","year":"2021","journal-title":"J Oral Pathol Med"},{"issue":"2528109","key":"key20251211105217_b69-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2025.2528109","article-title":"Mature tertiary lymphoid structures linked to HPV status and anti-PD-1 based chemoimmunotherapy response in head and neck squamous cell carcinoma","volume":"14","author":"Zhang","year":"2025","journal-title":"Oncoimmunology"},{"key":"key20251211105217_b70-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1177\/00220345231151685","article-title":"Tertiary lymphoid structure raises survival and immunotherapy in HPV-HNSCC","volume":"102","author":"Li","year":"2023","journal-title":"J Dent Res"},{"issue":"24","key":"key20251211105217_b71-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1038\/s41368-020-00092-3","article-title":"Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma","volume":"12","author":"Li","year":"2020","journal-title":"Int J Oral Sci"},{"key":"key20251211105217_b72-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.annonc.2024.11.008","article-title":"Tumor and blood B-cell abundance outperforms established immune checkpoint blockade response prediction signatures in head and neck cancer","volume":"36","author":"Chang","year":"2025","journal-title":"Ann Oncol"},{"issue":"101747","key":"key20251211105217_b73-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101747","article-title":"ABCB11 accumulated in immature tertiary lymphoid structures participates in xenobiotic metabolic process and predicts resistance to PD-1\/PD-L1 inhibitors in head and neck squamous cell carcinoma","volume":"36","author":"Ning","year":"2023","journal-title":"Transl Oncol"},{"issue":"101949","key":"key20251211105217_b74-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.101949","article-title":"Tertiary lymphoid structures in head and neck squamous cell carcinoma","volume":"44","author":"Zhu","year":"2024","journal-title":"Transl Oncol"},{"key":"key20251211105217_b75-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1158\/0008-5472.CAN-23-0379","article-title":"The tumor immune microenvironment architecture correlates with risk of recurrence in head and neck squamous cell carcinoma","volume":"83","author":"Weed","year":"2023","journal-title":"Cancer Res"},{"key":"key20251211105217_b76-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1038\/s41590-024-01992-w","article-title":"Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma","volume":"25","author":"Shu","year":"2024","journal-title":"Nat Immunol"},{"key":"key20251211105217_b77-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1158\/1078-0432.CCR-15-2762","article-title":"Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-cell responses, and superior prognosis in ovarian cancer","volume":"22","author":"Kroeger","year":"2016","journal-title":"Clin Cancer Res"},{"key":"key20251211105217_b78-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1002\/1878-0261.13403","article-title":"Tertiary lymphoid structures in head and neck squamous cell carcinoma improve prognosis by recruiting CD8+ T cells","volume":"17","author":"Wang","year":"2023","journal-title":"Mol Oncol"},{"issue":"pgad046","key":"key20251211105217_b79-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1093\/pnasnexus\/pgad046","article-title":"Transcriptional analysis links B cells and TERT expression to favorable prognosis in head and neck cancer","volume":"2","author":"Xian","year":"2023","journal-title":"PNAS Nexus"},{"key":"key20251211105217_b80-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/neuonc\/noae167","article-title":"Toll-like receptor agonists promote the formation of tertiary lymphoid structure and improve anti-glioma immunity","volume":"27","author":"Shen","year":"2025","journal-title":"Neuro Oncol"},{"issue":"e001906","key":"key20251211105217_b81-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001906","article-title":"STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment","volume":"9","author":"Chelvanambi","year":"2021","journal-title":"J Immunother Cancer"},{"key":"key20251211105217_b82-MCO-24-1-02916","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/cup.13953","article-title":"Tertiary lymphoid structures with overlapping histopathologic features of cutaneous marginal zone lymphoma during neoadjuvant cemiplimab therapy are associated with antitumor response","volume":"48","author":"Sweeney","year":"2021","journal-title":"J Cutan Pathol"},{"issue":"e1346","key":"key20251211105217_b83-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1346","article-title":"Single-cell transcriptome sequencing of B-cell heterogeneity and tertiary lymphoid structure predicts breast cancer prognosis and neoadjuvant therapy efficacy","volume":"13","author":"Wang","year":"2023","journal-title":"Clin Transl Med"},{"issue":"e009712","key":"key20251211105217_b84-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009712","article-title":"Alum-anchored IL-12 combined with cytotoxic chemotherapy and immune checkpoint blockade enhanced antitumor immune responses in head and neck cancer models","volume":"12","author":"Fabian","year":"2024","journal-title":"J Immunother Cancer"},{"issue":"794251","key":"key20251211105217_b85-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.794251","article-title":"Adenovirus Encoding tumor necrosis factor alpha and interleukin 2 induces a tertiary lymphoid structure signature in immune checkpoint inhibitor refractory head and neck cancer","volume":"13","author":"Clubb","year":"2022","journal-title":"Front Immunol"},{"issue":"1440530","key":"key20251211105217_b86-MCO-24-1-02916","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1440530","article-title":"Dendritic cell effector mechanisms and tumor immune microenvironment infiltration define TLR8 modulation and PD-1 blockade","volume":"15","author":"Ruiz-Torres","year":"2024","journal-title":"Front Immunol"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T08:52:22Z","timestamp":1765443142000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2025.2916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,11,14]]}},"URL":"https:\/\/doi.org\/10.3892\/mco.2025.2916","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]}}}